Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)

Name: Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)
Published: 2018
License: Public Domain

National Cancer Institute (NCI) · 2018

ClinicalTrials.gov · Datasets · License: Public Domain · 2018

Open Source ↗

advanced malignant solid neoplasm, recurrent childhood ependymoma, recurrent ewing sarcoma, recurrent glioma, recurrent hepatoblastoma, recurrent kidney wilms tumor, recurrent langerhans cell histiocytosis, recurrent malignant germ cell tumor, recurrent malignant glioma, recurrent medulloblastoma, recurrent neuroblastoma, recurrent non-hodgkin lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 863165
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.